LUMIBLAST
  • Project
    • Background
    • Workplan
  • Technology
  • Partners
    • Oslo University Hospital
    • National and Kapodistrian University of Athens
    • Universitat Politècnica de València
    • Knight Scientific Limited
    • University of Oslo
  • NEWS
  • Publications
  • Contact

Home > Project

Project

A paradigm shift in cancer therapy using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumours.
Lumiblast is a research project funded by the European research and innovation programme Horizon 2020. We aim to develop a breakthrough technology for cancer therapy using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumours. The project runs from October 2016 to March 2021.
Picture
Background

Picture
Workplan
 

Downloads

Project Factsheet
Picture


Picture
This project has received funding from the European Union's Horizon 2020 framework programme for research and innovation under grant agreement No 712921.
© accelopment Schweiz AG 2019. ALL RIGHTS RESERVED.
Disclaimer | Members Area

  • Project
    • Background
    • Workplan
  • Technology
  • Partners
    • Oslo University Hospital
    • National and Kapodistrian University of Athens
    • Universitat Politècnica de València
    • Knight Scientific Limited
    • University of Oslo
  • NEWS
  • Publications
  • Contact